Skip to main content
. 2023 Jul 20;7:100080. doi: 10.1016/j.obpill.2023.100080

Fig. 1.

Fig. 1

Mean change in BES score for patients with moderate or severe initial BES scores treated with semaglutide only (SEMA_ONLY, n ​= ​19), a combination of semaglutide and other anti-obesity medications (SEMA ​+ ​OAOM, n ​= ​13), and other anti-obesity medications only (OAOM, n ​= ​16). n ​= ​48. ∗∗p <.01. Error bars = standard error of the mean.